Category - Guidant

• Guidant warning letter wasn’t sent
• Boston Scientific, Guidant deal OK’d
• Shareholde­rs OK Boston Scientific buyout of Guidant
• Boston Scientific wins Guidant nod
• Troubled Guidant acquired
• Guidant bid salvo expected
• Boston Scientific’s richer bid for Guidant wins its support
• Guidant shifts OK to Boston Scientific
• Boston Scientific boosts Guidant bid to $26 billion
• Guidant accepts sweeter J&J bid
• Guidant board OKs J&J’s lower offer
• FDA warns Guidant about deficienci­es
• Guidant barred from exporting heart devices
• Guidant, Boston Scientific to talk offer
• New Guidant suitor seen ready to face risks
• Rival bid for Guidant brings relief to J&J
• New suitor bids $25 billion for Guidant
• Johnson & Johnson’s Guidant buy comes with legal problems
• Guidant sues to make J&J follow through
• Guidant sues J&J to compel deal
• Spitzer sues Guidant over defibrilla­tor
• N.Y. sues Guidant on eve of planned purchase by Johnson & Johnson
• Guidant deal threatened, suitor warns
• Johnson, Guidant quarrel over pact
• Johnson chief questions Guidant deal
• J&J’s takeover of Guidant needs FTC approval
• Guidant gets FDA approval to relaunch defibrilla­tor model
• FDA grants OK to Guidant to relaunch defibrilla­tor
• Guidant revises defibrilla­tor advice
• Guidant issues new implant warning
• Guidant warns doctors stop using 5 defibrilla­tors
• Guidant issues second advisory on defibrilla­tors
• 50,000 defibrilla­tors already implanted target of recall by Guidant Corp.
• Guidant recalling 50,000 heart defibrilla­tors
• Johnson-Guidant deal on its way
• J&J, Guidant hold talks in merger bid
• Guidant to acquire AFx inc. by April
• Guidant unit to quit making ‘stent-graft’
• Guidant unit to quit making ‘stent-graft’
• Guidant expansion atrophies